O2-Supplying Nanozymes Alleviate Hypoxia and Deplete Lactate to Eliminate Tumors and Activate Antitumor Immunity

• DOI: 10.1021/acsami.2c18960
• Publication Date: 2022-12-14T15:00:16Z
• Authors: Luyao Sun; Wendong Gao; Jie Liu; Jingjing Wang; Li Li; Haijun Yu; Zhi Ping Xu
• Keywords: tumor microenvironment regulation; hypoxia relief; 610; 500; Hydrogen Peroxide; layered double hydroxides; 01 natural sciences; Physical sciences; O2 self-generation; Mice; Engineering; Chemical sciences; Cell Line, Tumor; Neoplasms; Oself-generation; 0103 physical sciences; Tumor Microenvironment; Animals; Nanoparticles; Lactic Acid; tumor-associated macrophage reprogramming; Hypoxia; lactate depletion

Direct hypoxia alleviation and lactate depletion in the tumor microenvironment (TME) are promising for effective cancer therapy but still very challenging. To address this challenge, the current research directly reshapes the TME for inhibiting tumor growth and activating the antitumor immunity using a drug-free nanozyme. Herein, the acid-sensitive nanozymes were constructed based on peroxidized layered double hydroxide nanoparticles for O2 self-supply and self-boosted lactate depletion. The coloading of partially cross-linked catalase and lactate oxidase enabled the acid-sensitive nanozymes to promote three reactions, that is, (1) H2O2 generation from MgO2 hydrolysis (30% at pH 7.4 vs 63% at pH 6.0 in 8 h); (2) O2 generation from H2O2 (12% at pH 7.4 vs 21% at pH 6.0 in 2 h); and (3) lactate depletion by in situ generated O2 (50% under hypoxia vs 75% under normoxia in 24 h in vitro) in parallel or tandem. These promoted reactions together efficiently induced colon cancer cell apoptosis under the hypoxic conditions, significantly inhibited tumor growth (>95%), and suppressed distant tumor growth upon seven administrations in every 3 days and moreover transformed the immunosuppressive tumor into "hot" one in the colon tumor-bearing mouse model. This is the first example for a nanozyme that supplies sufficient O2 for hypoxia relief and lactate depletion, thus providing a new insight into drug-free nanomaterial-mediated TME-targeted cancer therapy.